Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Q/C TECHNOLOGIES, INC. Director's Dealing 2021

Apr 21, 2021

35313_dirs_2021-04-21_ccca17ba-5b3a-4995-b67f-db0e5809dcc7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MyMD Pharmaceuticals, Inc. (MYMD)
CIK: 0001321834
Period of Report: 2021-04-16

Reporting Person: Chapman Christopher C JR (Director, President, Chief Med. Officer)